The study will be conducted in three phases. Part A is a Phase 2, open-label, semi-sequential dose-ranging portion of the ...
First in class study of an investigational ACTH receptor antagonist aims to address significant unmet need in children and adolescents with classic CAHSAN DIEGO, Jan. 22, 2026(Nasdaq: CRNX) today anno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results